Skip to content
Screener

NextNav NN Issuance Of Warrants

Issuance Of Warrants at other companies

Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$409.25K
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$2.52M-75.7%
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$91.49K
Envoy Medical logo
Envoy MedicalCOCH
$882K+348%
CO2 Energy Transition logo
CO2 Energy TransitionNOEM
$51.75K
ADMA Biologics logo
ADMA BiologicsADMA
$1.4M

Other financials

Income statement

See full
Revenue$995.0K-35.3%
Gross profit-$1.1M-13.4%
Operating income-$19.3M-13.8%
Net income-$10.6M+81.9%
EPS (diluted)-$0.12+73.3%

Balance sheet

See full
Cash & equivalents$30.6M-79.7%
Total debt$281.5M+22.3%
Total equity-$90.0M-1,469%
Total assets$235.6M-12.3%

Cash flow

See full
Operating cash flow-$10.0M+17.6%
CapEx$10.0K-66.7%
Free cash flow-$10.1M+17.7%

Valuation

See full
Market cap$2.05B-1.1%
Enterprise value$2.3B+1.1%
P/S508×+177×

Profitability

See full
Gross margin-101.8%-194pp
Operating margin-1,801.2%+8,257pp
Net margin-3,506.9%+7,356pp
FCF margin-1,207.2%+2,928pp

Returns & leverage

See full
Return on equity-412.4%-701pp
Debt / equity35×+33.8×
Current ratio10.5×-6.3×

Where this comes from

Reported directly by NextNav in its filing.

Tagged under the XBRL concept nn:IssuanceOfWarrants.

The source filing: NextNav’s 10-K, filed March 17, 2026.

Filed
Mar 17, 2026, 12:00 AM EDT
Fiscal year
FY2025
Accession
0001554855-26-000328
Line itemYear Ended December 31, 2025Year Ended December 31, 2024
Cash and cash equivalents at end of period$44,757$39,330
Supplemental disclosures
Issuance of shares for asset purchase agreement$20,394
Issuance of warrants$9,006
Interest paid in cash$8,694$3,502
Reclassification of warrant liability to common stock warrants$1,241$11,523
Income taxes paid, net$186$195
Interest paid in shares$3,842

Item 10. [Directors, Executive Officers and Corporate Governance.](#TOC)

FAQ

What is NextNav's issuance of warrants?
NextNav (NN) reported issuance of warrants of -$2.25M in Q4 2025.
What is the long-term trend for NextNav's issuance of warrants?
Over 2 years (2021 to 2025), NextNav's issuance of warrants has grown at a -0.1% compound annual growth rate (CAGR), from $9.03M to -$9.01M.
What does issuance of warrants mean?
This metric tracks the financial impact or accounting value associated with the issuance of warrants to third parties, often as part of financing arrangements or service agreements. It reflects potential future dilution for existing shareholders and the cost of capital associated with these derivative instruments. Understanding this helps investors assess the company's long-term equity structure and financing costs.

Ask your AI about NextNav's issuance of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude